Phaleria macrocarpa Boerl. (Thymelaeaceae) Leaves Increase SR-BI Expression and Reduce Cholesterol Levels in Rats Fed a High Cholesterol Diet
Open Access
- 9 March 2015
- Vol. 20 (3) , 4410-4429
Abstract
In vitro and in vivo studies of the activity of Phaleria macrocarpa Boerl (Thymelaeaceae) leaves against the therapeutic target for hypercholesterolemia were done using the HDL receptor (SR-BI) and hypercholesterolemia-induced Sprague Dawley rats. The in vitro study showed that the active fraction (CF6) obtained from the ethyl acetate extract (EMD) and its component 2',6',4-trihydroxy-4'-methoxybenzophenone increased the SR-BI expression by 95% and 60%, respectively. The in vivo study has proven the effect of EMD at 0.5 g/kgbw dosage in reducing the total cholesterol level by 224.9% and increasing the HDL cholesterol level by 157% compared to the cholesterol group. In the toxicity study, serum glutamate oxalate transaminase (SGOT) and serum glutamate pyruvate transaminase (SGPT) activity were observed to be at normal levels. The liver histology also proved no toxicity and abnormalities in any of the treatment groups, so it can be categorized as non-toxic to the rat liver. The findings taken together show that P. macrocarpa leaves are safe and suitable as an alternative control and prevention treatment for hypercholesterolemia in Sprague Dawley rats.Keywords
This publication has 37 references indexed in Scilit:
- Phytochemistry and medicinal properties of Phaleria macrocarpa (Scheff.) Boerl. extractsPharmacognosy Reviews, 2013
- Anti-inflammatory Activity of the Major Compound from Methanol Extract of Phaleria macrocarpa LeavesJournal of Applied Sciences, 2012
- Bioassay-Guided Antidiabetic Study of Phaleria macrocarpa Fruit ExtractMolecules, 2012
- Hepatoprotective and antioxidant activity of a mangrove plant Lumnitzera racemosaAsian Pacific Journal of Tropical Biomedicine, 2011
- Mechanisms regulating hepatic SR-BI expression and their impact on HDL metabolismAtherosclerosis, 2011
- The role of the exogenous pathway in hypercholesterolaemiaEuropean Heart Journal Supplements, 2001
- Getting a Handle on “Good” Cholesterol with the High-Density Lipoprotein ReceptorNew England Journal of Medicine, 1999
- Cholesterol supplementation prevents necrosis and inflammation but enhances fibrosis in alcoholic liver disease in the ratHepatology, 1997
- Centrolobular Liver Fibrosis in the Hypercholesterolemic RabbitHepatology, 1996
- George Lyman Duff Memorial Lecture. Multifactorial etiology of hypercholesterolemia. Implications for prevention of coronary heart disease.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991